Search Results
10 results found for "Heidi Hamm"
Posts (5)
- Melatonin MT 2 receptor is expressed and potentiates contraction in human airway smooth muscle
receptor in native human and guinea pig airway smooth muscle and cultured human airway smooth muscle (HASM MT1/MT2 agonist ramelteon (10 µM) significantly inhibited forskolin-stimulated cAMP accumulation in HASM potentiated acetylcholine-stimulated [Ca2+]i increases, stress fiber formation through the MT2 receptor in HASM
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
cytokines, and, recently, gene editing techniques, have been tested to reduce the malignancy and generate a harmful
- G protein-coupled receptors that influence lifespan of human and animal models
We also discuss the possibility of using agonist or antagonist drugs, depending on the beneficial or harmful
Other Pages (4)
- Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against diet-induced obesity
McGuinness 5, Sheila Collins 1,5, Heidi E. Hamm 2 1 Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center About Heidi Hamm "Heidi E. Hamm, Ph.D. is the Aileen M. Hamm obtained her Ph.D. in 1980 from the Department of Zoology at the University of Texas-Austin and She gave the Fritz Lipmann Lecture at ASBMB in 2001. " Heidi Hamm on the web The Hamm Lab Vanderbilt
- Ep 89 with Dr. Patrick Sexton
Rand Medal (ASCEPT), Paxinos-Watson Award (Australian Neuroscience Society), Vane Medal (BPS), Gordon Hammes
- Content and Conduct Policy | Dr. GPCR Ecosystem
right; contains unlawful material, including illegal hate speech or pornography; exploits or otherwise harms Do not distribute content that harms or interferes with the operation of the networks, servers, or other Anyone using our Services to single someone out for malicious abuse, to threaten someone with serious harm In emergency situations, we may escalate imminent threats of serious harm to law enforcement.
Events (1)
- Development of GPCR Ligands as Therapeutic DrugsTickets: $0.00March 20, 2025 | 2:00 PM